These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7470363)

  • 1. Hexobarbitone disposition at different stages of intensive care treatment.
    Rietbrock I; Lazarus G; Richter E; Breimer DD
    Br J Anaesth; 1981 Mar; 53(3):283-93. PubMed ID: 7470363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.
    Vermeulen NP; Rietveld CT; Breimer DD
    Br J Clin Pharmacol; 1983 Apr; 15(4):459-64. PubMed ID: 6849782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.
    Smith DA; Chandler MH; Shedlofsky SI; Wedlund PJ; Blouin RA
    Br J Clin Pharmacol; 1991 Dec; 32(6):735-9. PubMed ID: 1768567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents.
    Richter E; Breimer DD; Zilly W
    Eur J Clin Pharmacol; 1980; 17(3):197-202. PubMed ID: 7363932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recovery.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1975 Oct; 18(4):433-40. PubMed ID: 1164825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients.
    Bailie GR; Cockshott ID; Douglas EJ; Bowles BJ
    Br J Anaesth; 1992 May; 68(5):486-91. PubMed ID: 1642937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Route- and dose-dependent pharmacokinetics of hexobarbitone in the rat: a re-evaluation of the use of sleeping times in metabolic studies.
    Van der Graaff M; Vermeulen NP; Breimer DD
    J Pharm Pharmacol; 1985 Aug; 37(8):550-4. PubMed ID: 2864415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the infusion of alfentanil in man.
    Fragen RJ; Booij LH; Braak GJ; Vree TB; Heykants J; Crul JF
    Br J Anaesth; 1983 Nov; 55(11):1077-81. PubMed ID: 6416281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
    Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
    Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.
    Heinemeyer G; Gramm HJ; Simgen W; Dennhardt R; Roots I
    Eur J Clin Pharmacol; 1987; 32(3):273-7. PubMed ID: 3595700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.
    Zilly W; Breimer DD; Richter E
    Eur J Clin Pharmacol; 1977 Apr; 11(4):287-93. PubMed ID: 862650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Pharmacokinetics of (+)-, (-)- and (plus or minus)-hexobarbitone in man after oral administration.
    Breimer DD; van Rossum JM
    J Pharm Pharmacol; 1973 Sep; 25(9):762-4. PubMed ID: 4148519
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the rat.
    Joeres RP; Vermeulen NP; Breimer DD
    Pharmacology; 1988; 36(3):210-6. PubMed ID: 3368506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmocokinetics of hexobarbital in man after intravenous infusion.
    Breimer DD; Honhoff C; Zilly W; Richter E; van Rossum JM
    J Pharmacokinet Biopharm; 1975 Feb; 3(1):1-11. PubMed ID: 1127574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Willems B; Butterworth RF
    Hepatology; 1989 Dec; 10(6):969-72. PubMed ID: 2511137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units.
    Müller C; Kremer W; Harlfinger S; Doroshyenko O; Jetter A; Hering F; Hünseler C; Roth B; Theisohn M
    Eur J Pediatr; 2006 Apr; 165(4):229-39. PubMed ID: 16496200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK; Ingall GB; Karler R
    Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of chlormethiazole following intravenous administration in the aged.
    Nation RL; Learoyd B; Barber J; Triggs EJ
    Eur J Clin Pharmacol; 1976; 10(6):407-15. PubMed ID: 1001356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease.
    Kates RE; Jaillon P; Rubenson DS; Winkle RA
    Clin Pharmacol Ther; 1980 Jul; 28(1):52-7. PubMed ID: 6156049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.